65678 Federal Register / Vol. 79, No. 214 / Wednesday, November 5, 2014 / Notices 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: October 29, 2014. 

David Clary, 

Program Analyst, Director, Office of Federal 

Advisory Committee Policy. 

[FR Doc. 2014–26201 Filed 11–4–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute Amended; 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Cancer 

Institute Special Emphasis Panel, 

November 19, 2014, 12:00 p.m. to 

November 19, 2014, 6:00 p.m., Hyatt 

Regency Hotel, 1 Bethesda Metro 

Center, Bethesda, MD, 20814 which was 

published in the Federal Register on 

October 06, 2014, 79FR60173. 

The meeting notice is being amended 

to change the meeting date from 

November 19, 2014 to December 10, 

2014. The meeting is closed to the 

public. 

Dated: October 30, 2014. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–26206 Filed 11–4–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Alternative Medicine; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Alternative Medicine 

Special Emphasis Panel; RFA AT–14–006: 

Center for Advancing Natural Products 

Innovation and Technology (U41). 

Date: December 19, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Martina Schmidt, Ph.D., 

Scientific Review Officer Office of Scientific 

Review, National Center for Complementary 

& Alternative Medicine, NIH, 6707 

Democracy Blvd., Suite 401, Bethesda, MD 

20892, 301–594–3456, schmidma@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Alternative Medicine, 

National Institutes of Health, HHS) 

Dated: October 30, 2014. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–26202 Filed 11–4–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute Amended; 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Cancer 

Institute Special Emphasis Panel, 

November 20, 2014, 8:00 a.m. to 

November 20, 2014, 5:00 p.m., Hyatt 

Regency Hotel, 1 Bethesda Metro 

Center, Bethesda, MD, 20814 which was 

published in the Federal Register on 

October 6, 2014, 79 FR 60173. 

The meeting notice is being amended 

to change the meeting date from 

November 20, 2014 to December 11, 

2014. The meeting is closed to the 

public. 

Dated: October 30, 2014. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–26205 Filed 11–4–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental and 

Craniofacial Research; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Dental and Craniofacial Research Special 

Emphasis Panel, Targeting Co-dependent 

Molecular Pathways in Oral Cancer (U01) 

Applications Review Panel. 

Date: December 9, 2014. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: DoubleTree by Hilton, Silver Spring, 

8727 Colesville Road, Silver Spring, MD 

20910. 

Contact Person: Victor Henriquez, Ph.D., 

Scientific Review Officer, DEA/SRB/NIDCR, 

6701 Democracy Blvd., Room 668, Bethesda, 

MD 20892–4878, 301–451–2405, henriquv@

nidcr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: October 29, 2014. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–26208 Filed 11–4–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 552b(c) 

(4) and 552b(c) (6), Title 5 U.S.C., as 

mstockstill on DSK4VPTVN1PROD with NOTICES